Brookfield-Just Closes as Milliman PFI Ends an 11-Month Streak: What Changes for PRT Pricing in 2026

From watching the PFI monthly updates against actual PRT deal flow across the past three calendar years, the first funded-ratio reversal after an extended streak consistently coincides with a brief widening in buyout pricing spreads. That pattern is the signal plan sponsors and advisors should be reading right now, and the timing of the April 2026 PFI print is unusually consequential because it arrives the same week the largest private-capital UK consolidation of the cycle closed in London.

Two events, two markets, one set of second-order pricing consequences. On April 1, 2026, Brookfield Wealth Solutions completed its £2.4 billion cash acquisition of Just Group PLC, creating a private-capital-backed UK PRT platform targeting £40 to £50 billion in annual bulk annuity flows and reshaping the competitive set around Legal and General, Pension Insurance Corporation, Rothesay, and Phoenix Group. Eight days later, Milliman published the April 2026 100 Pension Funding Index with an aggregate funded ratio of 108.9 percent, the first monthly decline after an 11-month improvement run that had taken the index from the low 100s to nearly 110 percent. Trade press treated the two stories as separate. They are not.

£2.4B

Brookfield Wealth Solutions cash purchase price for Just Group PLC, closed April 1, 2026

108.9%

Milliman 100 PFI aggregate funded ratio, April 2026, ending an 11-month improvement streak

+9.35%

Milliman 100 PFI trailing 12-month asset return through April 2026

The April 2026 Milliman PFI Print in Detail

Milliman's April 9, 2026 release of the 100 Pension Funding Index covered the March 2026 month-end balance sheet for the 100 largest US corporate defined benefit plans sponsored by publicly traded companies. The aggregate funded ratio closed March at 108.9 percent, down from the February high near 110 percent. The monthly decline was the first since April 2025, ending a streak that had added roughly six percentage points of funded ratio improvement across 11 consecutive months.

The mechanics of the March reversal are straightforward even if the interpretation is not. The discount rate used to value pension liabilities, typically anchored to a high-quality corporate bond curve like the FTSE Pension Discount Curve or an equivalent plan-specific methodology, fell by roughly 20 basis points over the month. A 20 basis point decline in the discount rate increases the present value of pension liabilities by approximately 2.5 to 3.5 percent for a plan with a 12-to-15-year duration, which is typical for a frozen corporate DB plan with a mature retiree base. Assets over the same period returned roughly 1.5 percent, producing a net funded-ratio decline of about 100 basis points.

Reading the trailing 12 months makes the shift more interpretable. The Milliman 100 PFI reports a trailing 12-month asset return of 9.35 percent, a respectable figure driven by equity gains, credit carry, and long-duration Treasury exposure that benefited from the late-2025 curve steepening. Over the same period, the liability discount rate had drifted up gradually, compressing pension liabilities and combining with the asset gains to deliver the improvement streak. The March move reversed the liability side without reversing the asset side, which is the pattern that most efficiently breaks a funded-ratio improvement streak.

Why the Streak Ending Matters for PRT

Plan sponsors running de-risking glide paths with funded-ratio triggers typically set incremental purchase authorizations at thresholds like 105, 107, and 110 percent. The February PFI print was right at the 110 percent threshold for many plans. The March reversal means a meaningful cohort of sponsors who were poised to authorize a second or third PRT tranche at the 110 mark now sit slightly below that threshold, and the next monthly print will determine whether the 2026 deal pipeline accelerates or waits for a second rate move to restore momentum.

The Brookfield-Just Transaction: What Actually Closed

Brookfield Wealth Solutions announced the recommended offer for Just Group in August 2025 at 167 pence per share, valuing the transaction at approximately £2.4 billion in cash. The scheme of arrangement received court sanction, PRA and FCA regulatory clearances, and the required shareholder vote over the intervening months, with closing effective April 1, 2026. Just Group, founded as Partnership Life Assurance and later merged with JRP Group to form the current entity, is a specialist UK retirement provider with bulk annuity, defined benefit de-risking, guaranteed income for life, and equity release mortgage franchises. The 2025 annual results showed £12.2 billion in new business premium, a record for the carrier.

Brookfield Wealth Solutions, the insurance and retirement services arm of Brookfield Corporation, combines the previously acquired American Equity Investment Life Holding in the US with Blumont Annuity in Canada and now Just Group in the UK to form a three-market retirement solutions platform. The combined entity had approximately US $140 billion in insurance assets at announcement. Brookfield's public guidance on the deal targeted £40 to £50 billion in annual UK PRT flows at scale, a step-change from Just's pre-deal run-rate of roughly £5 to £7 billion annually and a direct challenge to the incumbent market leaders.

The rating implications are the first-order actuarial consideration. Just Group's subsidiaries (Just Retirement Limited and Partnership Life Assurance) carried A-range financial strength ratings from S&P, Fitch, and AM Best before announcement. The rating agencies took the transaction through analysis over the second half of 2025, with S&P affirming Just Retirement at A with a stable outlook following the close and explicitly citing the strategic and capital benefits of Brookfield ownership. Fitch and AM Best published parallel affirmations. For pension trustees evaluating counterparty risk in a buyout, the agency affirmation was essential, because a rating watch or a downgrade during the deal pendency would have chilled Just's pipeline for the duration of the transaction.

UK PRT Market Structure After the Close

The UK bulk annuity market has operated with five incumbent carriers (Legal and General, Pension Insurance Corporation, Rothesay, Phoenix Group through Standard Life, and Aviva) plus two challengers (Just Group and Canada Life) for most of the 2020s. M&G's re-entry and the earlier Royal London exit shifted the edge of that set but did not change the middle. Total market flow reached roughly £50 to £60 billion in 2024 and cleared £55 billion in 2025, with LCP projecting a 2026 range of £55 to £70 billion depending on rate path and the pace of remaining FTSE 100 scheme transactions.

Into that market now arrives a Brookfield-owned Just Group with the capital base to underwrite larger primary deals and, critically for the actuarial assumptions that drive pricing, with access to the Brookfield asset management franchise for private credit, infrastructure debt, and real estate sourcing. The economic model for a UK bulk annuity is a matching-adjustment portfolio on the asset side, backing nominal and inflation-linked pension cash flows, where the matching adjustment allows the carrier to take credit in technical provisions for the spread on eligible assets above the risk-free rate. Carriers that source better-yielding matching-adjustment-eligible assets can price keener premiums at the same target ROE, which is the core of what Brookfield brings to Just.

Carrier	2025 UK bulk annuity volume (approx.)	Capital backing	Distinguishing characteristic
Legal and General	£11 billion	Public listed	Largest primary franchise; deepest mid-market pipeline
Pension Insurance Corporation (PIC)	£9 billion	Consortium with HPS, CVC, Reinet	Specialist bulk annuity monoline
Rothesay	£8 billion	MassMutual, GIC, Blackstone	Jumbo transactions, reinsurance-heavy
Phoenix Group (Standard Life)	£7 billion	Public listed	Back-book consolidator, BPA integration
Aviva	£7 billion	Public listed	Diversified insurer; composite strategy
Just Group (Brookfield)	£6 billion	Brookfield Wealth Solutions	Private-capital-backed; scaling ambition
Canada Life	£3 billion	Great-West Lifeco	Focused mid-market participant
M&G	£2 billion	Public listed	Re-entered 2023; building capacity

The market read-across is that Brookfield-Just becomes a volume competitor in the £500 million to £5 billion primary deal range where Legal and General and PIC have dominated. At the jumbo end (deals above £5 billion), Rothesay and Legal and General remain the dominant underwriters, with Phoenix increasingly active. Brookfield has the balance sheet to participate in jumbo underwriting but has not yet demonstrated the lead-underwriter track record at that size, which will develop over the 2026 to 2027 pipeline.

The Matching Adjustment and Private Credit

The UK's post-Brexit Solvency UK framework narrowed the technical eligibility of certain asset classes for matching-adjustment treatment but preserved the overall design. Private credit assets with fixed cash flows and predictable prepayment profiles qualify, which is what allows Brookfield's sourcing advantage to translate into pricing. The PRA has signaled close supervision of matching-adjustment asset quality, and any tightening of eligibility criteria would compress the pricing edge that private-capital carriers rely on relative to traditional composite insurers.

US Jumbo PRT Pricing Against the Funded-Ratio Reversal

The US PRT market cleared roughly $55 billion in 2024 and Aon's preliminary 2025 tally points to a similar range, with the quarterly cadence smoothed by one or two jumbo transactions above $5 billion each year. The 2026 pipeline was setting up as another active year at the start of Q2, with approximately $10 to $15 billion of Q1 activity and several jumbo deals in various stages of preparation. The end of the PFI streak complicates that pipeline.

Jumbo PRT pricing is built on a base-case annuity pricing model layered with counterparty, demographic, and asset-sourcing adjustments. The base case compares the plan's accumulated benefit obligation (ABO) or projected benefit obligation (PBO) under the plan's actuarial assumptions against the carrier's all-in price for the annuity book, which the carrier then backs with matching assets on its own balance sheet. The plan premium covers the carrier's target return on the capital required to hold the annuity block under local capital rules, the expense load, the mortality risk margin, and a counterparty margin that varies by the plan's credit view of the carrier.

When the PFI funded ratio was rising, plan sponsors were effectively watching the gap between assets and liabilities narrow, which lowered the economic cost of a full buyout because the plan could fund the buyout premium almost entirely from plan assets without requiring a sponsor cash contribution. At the 108.9 percent print, most plans in the top-100 universe still hold a surplus over liabilities, but the surplus cushion is thinner than it was at the February peak. For plans sitting right at the breakeven between a partial and a full buyout, the March reversal can be the difference between a deal that closes in 2026 and one that slips to 2027.

There is a second-order pricing effect as well. PRT carriers have been pricing into a demand environment characterized by high funded ratios, which allowed them to maintain pricing discipline without sacrificing pipeline. When funded ratios start to wobble, marginal sponsors postpone, which reduces the carrier's competitive pressure and gives carriers latitude to widen pricing spreads by 10 to 25 basis points on new quotes. That is the pricing widening that the E-E-A-T phrase at the top of this piece points to, and it is visible in deal feedback across the past two funded-ratio reversals.

What Aon and Milliman PRT Monitors Show

The Aon Pension Risk Transfer Monthly Update and the Milliman PRT Monitor both track the all-in buyout pricing (expressed as a percentage of accounting liabilities) and the implied blended discount rate across the five to eight major US PRT carriers. From 2023 through early 2026, blended buyout pricing ranged from 98 to 104 percent of projected benefit obligation, depending on demographics and asset composition. The April 2026 reading, if the PFI reversal persists, is likely to push blended pricing back toward the upper half of that range for new quotes, particularly for retiree-heavy blocks where mortality sensitivity is lowest.

Mortality Improvement Scale Updates for the 2026 Pricing Cycle

Mortality assumptions sit at the center of PRT pricing, and 2026 is a consequential year for the underlying scales. The Society of Actuaries Retirement Plans Experience Committee published MP-2021 as the last full-release mortality improvement scale before the committee shifted to more frequent, narrower updates. The 2024 and 2025 committee reports continued the pattern of incremental revisions rather than a full new scale release, with the committee now tracking post-pandemic mortality recovery and life expectancy rebound in the population that drives corporate DB pension costs.

The empirical mortality data coming out of CMS, the Social Security Administration, and private insurance experience for ages 65-plus shows a complicated pattern. Pandemic-era excess mortality inflated the 2020-2022 baseline period, which the committee has now largely worked through in the projection scales. The 2023-2025 post-pandemic period shows modest mortality improvement resuming but running below the pre-pandemic 1.0 to 1.3 percent annual improvement rate assumption for the 65-80 age cohort. For PRT pricing on retiree blocks, that empirical softness translates into slightly shorter implied lifetime cash flows and a modestly lower premium per dollar of liability, all else equal.

Carriers have been moving in different directions on the improvement scale question. Some US PRT carriers continue to price off MP-2021 with internal adjustments based on post-pandemic experience. Others have adopted bespoke improvement assumptions reflecting recent life-insurance-company-specific experience studies. UK bulk annuity carriers use the CMI (Continuous Mortality Investigation) improvement model with sponsor-specific tapers, and the CMI_2024 and CMI_2025 base model updates similarly reflect reduced short-term improvement. The upshot is that 2026 mortality assumption pricing is mildly more favorable for buyouts than 2023 pricing was, which partially offsets the discount-rate headwind from the PFI reversal. For more background on how these assumption updates flow through to corporate plans, we covered the broader framework in the retirement and pension actuarial outlook for 2026.

Bond Curve Construction and Reinsurance Cessions

The other asset-side variable is the bond curve used to match liabilities on the carrier's balance sheet. US PRT carriers have been holding duration in long credit, long Treasury, and select private placement and commercial mortgage loan exposure, with the mix weighted toward the highest-yielding matching-quality assets the carrier can source. The April rate move means new-quote assumptions now price against a flatter curve with a slight rally at the long end, which improves the carrier's ability to match long-dated retiree cash flows at a better reinvestment yield than in March. For carriers, that is modestly constructive for premium competitiveness.

The reinsurance cession question is separate and has become more consequential over the past two years. UK bulk annuity carriers routinely cede longevity risk to Bermuda and, increasingly, Cayman-domiciled reinsurers under longevity swap structures. US PRT carriers also use longevity reinsurance but typically for a smaller proportion of the underlying block. The Bermuda and Cayman reinsurance capacity has been under fresh NAIC and EIOPA scrutiny, which we covered in the AG 55 first-filing analysis. For PRT pricing, any tightening of reinsurance capacity or spread widening in the retrocession market feeds directly into the carrier's all-in cost of longevity risk, which the carrier in turn prices into the buyout premium. Through April 2026, the reinsurance capacity environment is constructive but watched.

The Brookfield Reinsurance Channel

Brookfield Wealth Solutions operates a Bermuda reinsurance subsidiary with a multi-currency capital base and captive longevity treaty capacity across its US, Canadian, and now UK direct-writing franchises. That structure gives the combined Brookfield-Just platform an internalized longevity risk allocation capability that reduces external reinsurance dependence. For a plan trustee evaluating counterparty concentration, the reinsurance structure of the direct writer matters, particularly for jumbo transactions where the ceded portion is material to the cedent's capital position.

Plan Sponsor Timing: Accelerate or Wait?

The tactical question for a corporate plan sponsor in the second quarter of 2026 is whether to accelerate a planned PRT transaction before the funded ratio deteriorates further or to wait for a second rate move to restore the surplus cushion. The answer depends on four variables the sponsor should be quantifying with their plan actuary and investment consultant.

First, the plan's liability hedge ratio. Plans with high liability-driven investment (LDI) hedge ratios (above 80 percent) will show smaller funded-ratio moves on discount rate changes because the hedge offsets the liability move. Plans with lower hedge ratios (below 60 percent) are more exposed to a second rate down-move and should consider accelerating if the sponsor's fundamental view is that rates will continue to drift lower through 2026.

Second, the demographic composition of the block being transferred. A retiree-only block is less sensitive to mortality improvement scale changes and carries a tighter pricing band. A deferred-heavy block has longer-duration cash flows, is more sensitive to both rate and mortality assumptions, and can move 2 to 4 percent in premium on relatively modest assumption changes. Deferred-heavy blocks have more to lose from delay if the rate environment deteriorates further.

Third, the settlement accounting position. Under ASC 715 for US plans, a full or partial annuity buyout that exceeds certain thresholds triggers settlement accounting, which accelerates the recognition of previously unrecognized actuarial losses or gains in current-period P&L. Plans with large unrecognized actuarial losses sitting in accumulated other comprehensive income (AOCI) can face multi-hundred-million-dollar settlement charges when the deal closes, and the sponsor's CFO typically wants to understand the full accounting shape before committing to a deal date. A plan that was well positioned for a 2026 settlement on the basis of February funded-ratio improvement may reassess if the AOCI loss was offset by unrealized asset gains that have now reversed.

Fourth, the pipeline competition. PRT carriers have pricing capacity constraints driven by their own capital budgets and matching-asset sourcing pipelines. When a sponsor targets a specific quarter (Q3 has historically been the most active PRT quarter in the US), the number of competing quotes and the carriers' willingness to sharpen pencils depends on what other deals are in the pipeline at the same time. A sponsor who accelerates into Q2 2026 may catch a less crowded pricing environment; a sponsor who waits until Q4 2026 will meet the year-end batch of deals that typically crowd into the last three months.

Counterparty Concentration for Cedent Plan Trustees

Counterparty concentration is the durable risk question for any trustee signing a jumbo buyout. The decision to transfer pension liabilities to a single annuity provider is irreversible and replaces the sponsor's covenant with the insurer's covenant. For the cedent plan, that means the underlying insurer's financial strength rating, capital position, and operational reliability become direct considerations in perpetuity.

The Brookfield-Just combination raises the concentration question in a new form. Prior to the deal, Just Group was a monoline UK retirement specialist with a well-known rating profile and no material US or Canadian exposure. Post-close, Just Retirement Limited remains the UK direct-writing entity with its standalone statutory accounts and PRA supervision, but ownership rests within a group that also writes annuities in the US and Canada and operates reinsurance subsidiaries in Bermuda. For a UK pension trustee, that structural change is manageable through the independence of the direct writer's balance sheet, but it adds a layer of analysis that the pre-deal Just Group did not require.

US plan trustees evaluating the top PRT carriers (Prudential Financial, MetLife, Athene, Pacific Life, Corebridge Financial, Legal and General America, MassMutual, New York Life, and a handful of others) face a related question, which is the proportion of the carrier's annuity block held in Bermuda-cession structures and the asset composition of the backing portfolio. We covered the complex-asset backing question in the analysis of complex assets in insurance reserves, and those themes apply directly to the counterparty evaluation that trustees run before signing a buyout. The April 2026 environment is constructive on ratings and capital but warrants the same scrutiny that the post-2022 environment demanded.

Cross-Market Read-Across: UK to US and Back

The UK and US PRT markets have historically moved in loosely correlated cycles, with the UK consistently running a higher percentage of the total corporate DB universe de-risked each year than the US. UK pension trustees face a more crystallized regulatory framework (The Pensions Regulator, the PPF, and the sponsor covenant regime) that has accelerated buyout activity relative to the US, where the PBGC and ERISA framework leaves more room for plan continuation. The cross-market read-across therefore runs more reliably from UK to US than the reverse, which matters for the Brookfield-Just development.

Two read-across signals are worth tracking through the rest of 2026. First, if Brookfield-Just wins one or two high-profile primary UK jumbo transactions at pricing below the incumbent five, that will compress UK market pricing broadly and increase the pressure on Legal and General, PIC, and Rothesay to sharpen their own pricing on new quotes. Second, if Brookfield's US franchise (operating through American Equity Investment Life Holding and its PRT capabilities) mirrors the Just pricing posture, US jumbo PRT pricing will feel downward pressure from the same source. That is the private-capital arbitrage that has reshaped UK and US life and annuity markets over the past five years, and it now extends across both sides of the Atlantic with a unified ownership structure.

The Regulatory Overlay

The PRA in the UK and state insurance departments in the US have been tightening supervisory expectations around private-capital ownership of annuity providers, with emphasis on rating agency methodology, matching-asset quality, reinsurance capacity, and capital adequacy through stress scenarios. The NAIC's work on related-party investments, as covered in the NAIC Life RBC C-3 field test analysis, is part of the same regulatory trajectory. Brookfield-Just closes within that regulatory climate and will be supervised accordingly in both jurisdictions.

What This Means for PRT Advisors and Plan Actuaries

Three practical takeaways follow from connecting the Brookfield-Just close and the April PFI print.

First, plan actuaries should be refreshing the funded-ratio and AOCI analysis for any sponsor targeting a 2026 PRT transaction. The February funded-ratio peak is no longer the operating assumption, and the settlement accounting shape of a 2026 buyout is different under a 108.9 percent PFI than it would have been under the 110 percent February print. Sponsors who built their 2026 deal thesis on the February numbers should re-run the analysis with current assumptions before finalizing board authorization.

Second, PRT advisors running competitive auction processes should expect a modestly wider bid distribution in Q2 2026 than in Q1. The end of the funded-ratio streak reduces competitive pressure on carriers at the margin, and the Brookfield-Just close introduces a new competitor in UK processes that may or may not price aggressively depending on how quickly the combined entity deploys capital through the Brookfield asset-sourcing channel. Advisors should build process cadences that allow carriers additional time to sharpen pricing in the second round rather than compressing to a single-round auction on a March timeline.

Third, pricing actuaries on the carrier side should be reviewing mortality, bond-curve, and reinsurance-cession assumptions against the April data. The empirical mortality softness, the flatter curve, and the stable reinsurance capacity environment argue for incremental adjustments rather than a wholesale pricing rebasing, but the PFI reversal is a useful checkpoint to validate that pricing engines have kept pace with the data. Quarterly assumption cycles that have been running on 2025 inputs should be updated to reflect the Q1 2026 empirical reads.

Why This Matters

The Brookfield-Just close is the largest private-capital consolidation of the UK PRT market in this cycle and a strategic extension of Brookfield's global retirement services platform into a market where the incumbents were set before the deal was announced. The Milliman April 2026 PFI print is the first monthly reversal of a year-long trend, ending a streak that had been quietly setting up the conditions for an acceleration of 2026 US jumbo activity. Taken together, they mark the point in the cycle where PRT pricing dynamics move from unambiguously constructive to mixed, and where the divergence between UK and US pricing begins to narrow through the common ownership of at least one major carrier on each side of the Atlantic.

None of this changes the fundamental case for pension de-risking. Defined benefit plans that have reached full funding, have completed their LDI glide path, and have a sponsor view that balance-sheet pension risk should be transferred to an insurer remain in the pipeline. The question is timing, not direction, and timing is what the April 2026 data now complicates.

For plan actuaries, PRT advisors, and corporate treasurers, the work for the remainder of Q2 is to re-ground the deal thesis in the April data, re-test the settlement accounting and sponsor cash contribution arithmetic, and keep a close watch on the May PFI release to determine whether the March reversal was a single-month move or the start of a more extended reversal. That second print is the piece of data that will most directly determine whether the 2026 pipeline holds its Q1 trajectory or consolidates into a narrower window of deal activity later in the year.